Skip to main content

Advertisement

SpringerLink
Log in

European Guidelines on Pericardial Diseases: a Focused Review of Novel Aspects

  • Pericardial Disease (AL Klein, Section Editor)
  • Published:
Current Cardiology Reports Aims and scope Submit manuscript

Abstract

Pericardial diseases are not uncommon in daily clinical practice. The spectrum of these syndromes includes acute and chronic pericarditis, pericardial effusion, constrictive pericarditis, congenital defects, and neoplasms. The extent of the high-quality evidence on pericardial diseases has expanded significantly since the first international guidelines on pericardial disease management were published by the European Society of Cardiology in 2004. The clinical practice guidelines provide a useful reference for physicians in selecting the best management strategy for an individual patient by summarizing the current state of knowledge in a particular field. The new clinical guidelines on the diagnosis and management of pericardial diseases that have been published by the European Society of Cardiology in 2015 represent such a tool and focus on assisting the physicians in their daily clinical practice. The aim of this review is to outline and emphasize the most clinically relevant new aspects of the current guidelines as compared with its previous version published in 2004.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Maisch B, Seferović PM, Ristić AD, Task Force on the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology. Guidelines on the diagnosis and management of pericardial diseases executive summary. Eur Heart J. 2004;25:587–610.

    Article  PubMed  Google Scholar 

  2. Imazio M, Demichelis B, Parrini I, et al. Day-hospital treatment of acute pericarditis: a management program for outpatient therapy. J Am Coll Cardiol. 2004;43:1042–6.

    Article  PubMed  Google Scholar 

  3. Sagristà-Sauleda J, Angel J, Sánchez A, et al. Effusive-constrictive pericarditis. N Engl J Med. 2004;350:469–75.

    Article  PubMed  Google Scholar 

  4. Reuter H, Burgess LJ, Doubell AF. Epidemiology of pericardial effusions at a large academic hospital in South Africa. Epidemiol Infect. 2005;133:393–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Imazio M, Bobbio M, Cecchi E, et al. Colchicine in addition to conventional therapy for acute pericarditis: results of the COlchicine for acute PEricarditis (COPE) trial. Circulation. 2005;112:2012–6.

    Article  CAS  PubMed  Google Scholar 

  6. Imazio M, Bobbio M, Cecchi E, et al. Colchicine as first-choice therapy for recurrent pericarditis: results of the CORE (COlchicine for REcurrent pericarditis) trial. Arch Intern Med. 2005;165:1987–91.

    Article  CAS  PubMed  Google Scholar 

  7. Mayosi BM, Wiysonge CS, Ntsekhe M, et al. Clinical characteristics and initial management of patients with tuberculous pericarditis in the HIV era: the Investigation of the Management of Pericarditis in Africa (IMPI Africa) registry. BMC Infect Dis. 2006;6:2.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Imazio M, Cecchi E, Demichelis B, et al. Indicators of poor prognosis of acute pericarditis. Circulation. 2007;115:2739–44.

    Article  PubMed  Google Scholar 

  9. Reuter H, Burgess LJ, Louw VJ, et al. The management of tuberculous pericardial effusion: experience in 233 consecutive patients. Cardiovasc J S Africa. 2007;18:20–5.

    CAS  Google Scholar 

  10. Imazio M, Brucato A, Cumetti D, et al. Corticosteroids for recurrent pericarditis: high versus low doses: a nonrandomized observation. Circulation. 2008;118:667–71.

    Article  CAS  PubMed  Google Scholar 

  11. Imazio M, Cecchi E, Demichelis B, et al. Myopericarditis versus viral or idiopathic acute pericarditis. Heart. 2008;94:498–501.

    Article  CAS  PubMed  Google Scholar 

  12. Meurin P, Tabet JY, Thabut G, French Society of Cardiology. Nonsteroidal anti-inflammatory drug treatment for postoperative pericardial effusion: a multicenter randomized, double-blind trial. Ann Intern Med. 2010;152:137–43.

    Article  PubMed  Google Scholar 

  13. Imazio M, Trinchero R, Brucato A, et al. COlchicine for the Prevention of the Post-pericardiotomy Syndrome (COPPS): a multicentre, randomized, double-blind, placebo-controlled trial. Eur Heart J. 2010;31:2749–54.

    Article  CAS  PubMed  Google Scholar 

  14. Imazio M, Brucato A, Maestroni S, et al. Prevalence of C-reactive protein elevation and time course of normalization in acute pericarditis: implications for the diagnosis, therapy, and prognosis of pericarditis. Circulation. 2011;123:1092–7.

    Article  CAS  PubMed  Google Scholar 

  15. Imazio M, Brucato A, Maestroni S, et al. Risk of constrictive pericarditis after acute pericarditis. Circulation. 2011;124:1270–5.

    Article  PubMed  Google Scholar 

  16. Imazio M, Brucato A, Cemin R, CORP (COlchicine for Recurrent Pericarditis) Investigators, et al. Colchicine for recurrent pericarditis (CORP): a randomized trial. Ann Intern Med. 2011;155:409–14.

    Article  PubMed  Google Scholar 

  17. Khandaker MH, Schaff HV, Greason KL, et al. Pericardiectomy vs medical management in patients with relapsing pericarditis. Mayo Clin Proc. 2012;87:1062–70.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Imazio M, Brucato A, Barbieri A, et al. Good prognosis for pericarditis with and without myocardial involvement: results from a multicenter, prospective cohort study. Circulation. 2013;128:42–9. At present, largest prospective cohort study on the prognosis of patients with pericarditis and myocardial involvement.

    Article  CAS  PubMed  Google Scholar 

  19. Imazio M, Brucato A, Cemin R, ICAP Investigators, et al. A randomized trial of colchicine for acute pericarditis. N Engl J Med. 2013;369:1522–8. Multicenter randomized double-blinded controlled trial on the safety and efficacy of colchicine in acute pericarditis.

    Article  CAS  PubMed  Google Scholar 

  20. Shakti D, Hehn R, Gauvreau K, et al. Idiopathic pericarditis and pericardial effusion in children: contemporary epidemiology and management. J Am Heart Assoc. 2014;3, e001483.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Kytö V, Sipilä J, Rautava P. Clinical profile and influences on outcomes in patients hospitalized for acute pericarditis. Circulation. 2014;130:1601–6.

    Article  PubMed  Google Scholar 

  22. Imazio M, Belli R, Brucato A, et al. Efficacy and safety of colchicine for treatment of multiple recurrences of pericarditis (CORP-2): a multicenter, double-blind, placebo-controlled, randomized trial. Lancet. 2014;383:2232–7. First multicenter randomized double-blinded controlled trial on the safety and efficacy of colchicine for multiple recurrences of pericarditis.

    Article  CAS  PubMed  Google Scholar 

  23. Mayosi BM, Ntsekhe M, Bosch J, et al. Prednisolone and Mycobacterium indicus pranii in tuberculous pericarditis. N Engl J Med. 2014;371:1121–30. Prospective randomized controlled trial on the efficacy of adjunctive glucocorticoid and Mycobacterium indicus pranii therapy in tuberculous pericarditis.

  24. Imazio M, Brucato A, Ferrazzi P, et al. Colchicine for prevention of postpericardiotomy syndrome and postoperative atrial fibrillation: the COPPS-2 randomized clinical trial. Jama. 2014;312:1016–23. Prospective randomized controlled trial on the safety and efficacy of colchicine in prevention of postpericardiotomy syndrome and post-operative atrial fibrillation.

    Article  CAS  PubMed  Google Scholar 

  25. Alraies MC, AlJaroudi W, Yarmohammadi H, et al. Usefulness of cardiac magnetic resonance–guided management in patients with recurrent pericarditis. Am J Cardiol. 2015;115:542–7.

    Article  PubMed  Google Scholar 

  26. Gouriet F, Levy PY, Casalta JP, et al. Etiology of pericarditis in a prospective cohort of 1162 cases. Am J Med. 2015;128:784.e1-8.

    Article  PubMed  Google Scholar 

  27. Sagristá-Sauleda J, AlmenarBonet L, Angel Ferrer J, et al. The clinical practice guidelines of the Sociedad Española de Cardiología on pericardial pathology. Rev Esp Cardiol. 2000;53(3):394–412.

    Article  PubMed  Google Scholar 

  28. Montera MW, Mesquita ET, Colafranceschi AS, Sociedade Brasileira de Cardiologia, et al. I Brazilian guidelines on myocarditis and pericarditis. Arq Bras Cardiol. 2013;100:1–36. Brazilian guidelines on management of pericardial diseases.

    Article  PubMed  Google Scholar 

  29. Authors/Task Force Members, Adler Y, Charron P, Imazio M, et al. ESC Guidelines for the diagnosis and management of pericardial diseases: the Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC) Endorsed by: the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2015;36(42):292–2964. doi:10.1093/eurheartj/ehv318.

    Google Scholar 

  30. Mutyaba AK, Balkaran S, Cloete R, et al. Constrictive pericarditis requiring pericardiectomy at Groote Schuur Hospital, Cape Town, South Africa: causes and perioperative outcomes in HIV era (1990–2012). J Thorac Cardiovasc Surg. 2014;148:3058–3065.e1.

    Article  PubMed  Google Scholar 

  31. Imazio M. Contemporary management of pericardial diseases. Curr Opin Cardiol. 2012;27:308–17.

    Article  PubMed  Google Scholar 

  32. LeWinter MM. Clinical practice. Acute pericarditis. N Engl J Med. 2014;371:2410–6.

    Article  PubMed  Google Scholar 

  33. Imazio M, Gaita F. Diagnosis and treatment of pericarditis. Heart. 2015;101:1159–68.

    Article  PubMed  Google Scholar 

  34. Imazio M, Spodick DH, Brucato A, et al. Controversial issues in the management of pericardial diseases. Circulation. 2010;121:916–28.

    Article  PubMed  Google Scholar 

  35. Sliwa K, Mocumbi AO. Forgotten cardiovascular diseases in Africa. Clin Res Cardiol. 2010;99:65–74.

    Article  PubMed  Google Scholar 

  36. Klein AL, Abbara S, Agler DA, et al. American Society of Echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with pericardial disease: endorsed by the Society for Cardiovascular Magnetic Resonance and Society of Cardiovascular Computed Tomography. J Am Soc Echocardiogr. 2013;26:965–1012.e15. American Society of Echocardiography consensus statement on multimodality imaging in pericardial diseases.

    Article  PubMed  Google Scholar 

  37. Permanyer-Miralda G. Acute pericardial disease: approach to the aetiologic diagnosis. Heart. 2004;90:252–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Lilly LS. Treatment of acute and recurrent idiopathic pericarditis. Circulation. 2013;127:1723–6.

    Article  PubMed  Google Scholar 

  39. Seidenberg PH, Haynes J. Pericarditis: diagnosis, management, and return to play. Curr Sports Med Rep. 2006;5:74–9.

    Article  PubMed  Google Scholar 

  40. Pelliccia A, Corrado D, Bjørnstad HH, et al. Recommendations for participation in competitive sport and leisure-time physical activity in individuals with cardiomyopathies, myocarditis and pericarditis. Eur J Cardiovasc Prev Rehabil. 2006;13:876–85.

    Article  PubMed  Google Scholar 

  41. Horneffer PJ, Miller RH, Pearson TA, et al. The effective treatment of postpericardiotomy syndrome after cardiac operations. A randomized placebo-controlled trial. J Thorac Cardiovasc Surg. 1990;100:292–6.

    CAS  PubMed  Google Scholar 

  42. Lotrionte M, Biondi-Zoccai G, Imazio M, et al. International collaborative systematic review of controlled clinical trials on pharmacologic treatments for acute pericarditis and its recurrences. Am Heart J. 2010;160:662–70.

    Article  CAS  PubMed  Google Scholar 

  43. Alabed S, Cabello JB, Irving GJ, et al. Colchicine for pericarditis. Cochrane Database Syst Rev. 2014;8, CD010652.

    PubMed  Google Scholar 

  44. Vianello F, Cinetto F, Cavraro M, et al. Azathioprine in isolated recurrent pericarditis: a single centre experience. Int J Cardiol. 2011;147:477–8.

    Article  PubMed  Google Scholar 

  45. Imazio M, Lazaros G, Brucato A, et al. Intravenous human immunoglobulin for refractory recurrent pericarditis. A systematic review of all published cases. J Cardiovasc Med (Hagerstown). 2015.

  46. Lazaros G, Imazio M, Brucato A, et al. Anakinra: an emerging option for refractory idiopathic recurrent pericarditis. A systematic review of published evidence. J Cardiovasc Med(Hagerstown). 2015.

  47. Caforio AL, Pankuweit S, Arbustini E, European Society of Cardiology Working Group on Myocardial and Pericardial Diseases, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2013;34:2636–48. Consensus document on myocarditis management of European Society of Cardiology Working group on Myocardial and Pericardial diseases.

    Article  PubMed  Google Scholar 

  48. Imazio M, Trinchero R. Myopericarditis: etiology, management and prognosis. Int J Cardiol. 2008;127:17–26.

    Article  PubMed  Google Scholar 

  49. Mayosi BM, Burgess LJ, Doubell AF. Tuberculous pericarditis. Circulation. 2005;112:3608–16.

    Article  PubMed  Google Scholar 

  50. Imazio M, Adler Y. Management of pericardial effusion. Eur Heart J. 2013;34:1186–97.

    Article  PubMed  Google Scholar 

  51. Haley JH, Tajik AJ, Danielson GK, et al. Transient constrictive pericarditis: causes and natural history. J Am Coll Cardiol. 2004;43:271–5.

    Article  PubMed  Google Scholar 

  52. Ntsekhe M, Wiysonge CS, Commerford PJ, et al. The prevalence and outcome of effusive constrictive pericarditis: a systematic review of the literature. Cardiovasc J Afr. 2012;23:281–5.

    Article  PubMed  PubMed Central  Google Scholar 

  53. Cosyns B, Plein S, Nihoyanopoulos P, on behalf of the EuropeanAssociation of Cardiovascular Imaging (EACVI) and European Society of Cardiology Working group (ESC WG) on Myocardial and Pericardial Diseases, et al. European Association of Cardiovascular Imaging (EACVI) position paper: multimodality imaging in pericardial disease. Eur Heart J Cardiovasc Imaging. 2014;16:12–31. Consensus statement of European Society of Cardiology Working group on Myocardial and Pericardial Diseases on multimodality imaging in pericardial diseases.

    Article  PubMed  Google Scholar 

  54. Bogaert J, Francone M. Pericardial disease: value of CT and MR imaging. Radiology. 2013;267:340–56.

    Article  PubMed  Google Scholar 

  55. Psychidis-Papakyritsis P, de Roos A, Kroft LJM. Functional MRI of congenital absence of the pericardium. AJR Am J Roentgenol. 2007;189:W312–4.

    Article  PubMed  Google Scholar 

  56. Coolen J, De Keyzer F, Nafteux P, et al. Malignant pleural disease: diagnosis by using diffusion-weighted and dynamic contrast-enhanced MR imaging – initial experience. Radiology. 2012;263:884–92.

    Article  PubMed  Google Scholar 

  57. Zurick AO, Bolen MA, Kwon DH, et al. Pericardial delayed hyperenhancement with CMR imaging in patients with constrictive pericarditis undergoing surgical pericardiectomy. A case series with histopathological correlation. JACC Cardiovasc Imaging. 2011;4(11):1180–91.

    Article  PubMed  Google Scholar 

  58. Talreja DR, Nishimura RA, Oh JK, et al. Constrictive pericarditis in the modern era: novel criteria for diagnosis in the cardiac catheterization laboratory. J Am Coll Cardiol. 2008;51:315–9.

    Article  PubMed  Google Scholar 

  59. Mayosi BM, Wiysonge CS, Ntsekhe M, et al. Mortality in patients treated for tuberculous pericarditis in sub-Saharan Africa. S Afr Med J. 2008;98:36–40.

    PubMed  Google Scholar 

  60. Pandie S, Peter JG, Kerbelker ZS, et al. Diagnostic accuracy of quantitative PCR (Xpert MTB/RIF) for tuberculous pericarditis compared to adenosine deaminase and unstimulated interferon-γ in a high burden setting: a prospective study. BMC Med. 2014;12:101.

    Article  PubMed  PubMed Central  Google Scholar 

  61. Imazio M, Hoit BD. Post-cardiac injury syndromes. An emerging cause of pericardial disease. Int J Cardiol. 2013;168:648–52.

    Article  PubMed  Google Scholar 

  62. Mott AR, Fraser CD, Kusnoor AV, et al. The effect of short-term prophylactic methylprednisolone on the incidence and severity of postpericardiotomy syndrome in children undergoing cardiac surgery with cardiopulmonary bypass. Pediatr Cardiol. 2001;37(6):1700–6.

    CAS  Google Scholar 

  63. Gill PJ, Forbes K, Coe JY. The effect of short-term prophylactic acetylsalicylic acid on the incidence of postpericardiotomy syndrome after surgical closure of atrial septal defects. Pediatr Cardiol. 2009;30(8):1061–7.

    Article  PubMed  Google Scholar 

  64. Bunge JJH, van Osch D, Dieleman JM, et al. Dexamethasone for the prevention of postpericardiotomy syndrome: a DExamethasone for cardiac surgery substudy. Am Heart J. 2014;168(1):126–31.

    Article  CAS  PubMed  Google Scholar 

  65. Raatikka M, Pelkonem PM, Karjalainen J, et al. Recurrent pericarditis in children and adolescents. J Am Coll Cardiol. 2003;42:759–64.

    Article  PubMed  Google Scholar 

  66. Picco P, Brisca G, Traverso F, et al. Successful treatment of idiopathic recurrent pericarditis in children with interleukin-1β receptor antagonist (anakinra): an unrecognized autoinflammatory disease? Arthritis Rheum. 2009;60:264–8.

    Article  CAS  PubMed  Google Scholar 

  67. Finetti M, Insalaco A, Cantarini L, et al. Long term efficacy interleukin-1 receptor antagonist (anakinra)in steroid dependent and colchicine-resistant recurrent pericarditis. J Pediatr. 2014;164:1425–31.

    Article  CAS  PubMed  Google Scholar 

  68. Brucato A, Imazio M, Curri S, et al. Medical treatment of pericarditis during pregnancy. Int J Cardiol. 2010;144:413–4.

    Article  PubMed  Google Scholar 

  69. Imazio M, Brucato A, Rampello S, et al. Management of pericardial disease during pregnancy. J Cardiovasc Med (Hagerstown). 2010;11:557–62.

    Article  Google Scholar 

  70. Østensen M, Khamashta M, Lockshin M, et al. Anti-inflammatory and immunosuppressive drugs and reproduction. Arthritis Res Ther. 2006;8:209.

    Article  PubMed  PubMed Central  Google Scholar 

  71. Maisch B, Ristic AD, Seferovic M, Tsang TMJ. Interventional pericardiology: pericardiocentesis, pericardioscopy, pericardial biopsy, balloon pericardiotomy, and intrapericardial therapy. Heidelberg: Springer; 2011.

    Book  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine D, The Chaim Sheba Medical Center, Tel Hashomer, The Sackler School of Medicine Tel Aviv University, Tel Aviv, Israel

    Alexander Fardman

  2. Université de Versailles-Saint Quentin, Hôpital Ambroise Paré, AP-HP, Boulogne-Billancourt, France

    Philippe Charron

  3. Cardiology Department, Maria Vittoria Hospital and Department of Public Health and Pediatrics, University of Torino, Torino, Italy

    Massimo Imazio

  4. Management, The Chaim Sheba Medical Center, Tel Hashomer, The Sackler School of Medicine Tel Aviv University, Tel Aviv, Israel

    Yehuda Adler

Authors
  1. Alexander Fardman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Philippe Charron
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Massimo Imazio
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yehuda Adler
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yehuda Adler.

Ethics declarations

Conflict of Interest

Alexander Fardman, Philippe Charron, Massimo Imazio, and Yehuda Adler declare that they have no conflict of interest.

Dr. Imazio’ s institution has received research grants from Acarpia srl (Madeira, Portugal) and SOBI (Stockholm, Sweden). Drs. Imazio, Adler, and Charron have been members of the Task Force for 2015 ESC guidelines on pericardial diseases.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on Pericardial Disease

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fardman, A., Charron, P., Imazio, M. et al. European Guidelines on Pericardial Diseases: a Focused Review of Novel Aspects. Curr Cardiol Rep 18, 46 (2016). https://doi.org/10.1007/s11886-016-0721-1

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11886-016-0721-1

Keywords

Search

Navigation